KO
38
-3
INTC
41
4
CB
57
2
KMI
69
-2
PLD
45
-5
BMY
55
-8
AEP
54
6
MCD
52
-5
DIS
85
3
CNP
54
10
PDCO
29
2
OI
42
-3
ZBH
65
3
EQT
51
-3
MU
28
-3
ETR
65
2
PEP
39
-9
AON
54
2
WMB
68
2
ILMN
32
-9
KO
38
-3
INTC
41
4
CB
57
2
KMI
69
-2
PLD
45
-5
BMY
55
-8
AEP
54
6
MCD
52
-5
DIS
85
3
CNP
54
10
PDCO
29
2
OI
42
-3
ZBH
65
3
EQT
51
-3
MU
28
-3
ETR
65
2
PEP
39
-9
AON
54
2
WMB
68
2
ILMN
32
-9
Financhill
Back

Ocular Therapeutix Vs. Neurogene Industry Stock Comparison

Buy
54

OCUL
Ocular Therapeutix

Last Price:
9.17
Seasonality Move:
38.49%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Buy
54
Ocular Therapeutix (OCUL) is a Buy

Is Ocular Therapeutix a Buy, Sell or Hold?

  • The current Ocular Therapeutix [OCUL] share price is $9.16. The Score for OCUL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • OCUL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OCUL Stock Price Chart

What is Ocular Therapeutix's stock price today?

  • The Ocular Therapeutix share price today is $9.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCUL is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

OCUL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 34.86 Sell
Chaikin Money Flow: -1254672 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.18 - 11.3) Sell
Bollinger Bands (100): (7.63 - 10.19) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

OCUL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.51 Sell
20-day SMA: 10.76 Sell
50-day SMA: 9.83 Sell
200-day SMA: 8 Buy
8-day EMA: 10.25 Sell
20-day EMA: 10.43 Sell
50-day EMA: 9.92 Sell
200-day EMA: 7.96 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Ocular Therapeutix Earnings Growth & OCUL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.03 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Ocular Therapeutix Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):